Primary cardiac lymphoma
29 July 2022 – molecular analysis planned as well, grant, ethics approval received
7 Feb 2023 – getting through ethics approval received
20 July 2023 – Been waiting for ethics & governance approval. Molecular analaysis involved. Already have the clinical data.
24 November 2023 – Change in registrar, waiting on governance approval
29 February 2024 – Still waiting on governance to execute MTA